Ana Lisa Carr St
GLP-1 Receptor Agonists (e.g., semaglutide, liraglutide) Increase insulin secretion in response to food Reduce glucagon release (which lowers blood sugar) Slows gastric emptying (which helps with post-meal glucose excursions) Reduces appetite and induces satiety which leads to weight loss GLP-1/GIP Receptor Agonists (e.g., tirzepatide) GLP-1 effects (same as above) GIP effect: further enhances insulin secretion Both medications help with blood sugar control and weight loss, but Mounjaros dual mechanism may offer stronger effects on insulin secretion, which improves A1c levels
These compounded preparations are subject to different regulatory standards than FDA-approved manufactured drugs
Heres how myBMIs regulated, pharmacist-led care fits among todays most popular GLP-1 programs, from fast-access start-ups to full-service coaching clinics: Swipe to scroll the table below Real User Experience With myBMI myBMI has a 4.2-star rating from over 1,000 reviews on Trustpilot, earning a Great overall score
Clinicians have refined dosing schedules, dietary guidance, and anti-nausea strategies over years of prescribing experience
After a median follow-up of 4.6 years across the full VESALIUS-CV trial, patients in the high-risk diabetes subgroup showed a 29% reduction in three-point major adverse cardiovascular events and a 21% reduction in four-point events compared with placebo the most robust cardiovascular benefit yet documented for a PCSK9 inhibitor in a population that had never had established cardiovascular disease
